Company Filing History:
4 out of 38 
4 out of 329 
Years Active: 2018-2024
Title: Henry J Zecca: Innovator in KRas G12C Inhibitors
Introduction
Henry J Zecca is a notable inventor based in Boulder, CO (US), recognized for his contributions to the field of pharmaceutical innovations. He holds a total of 4 patents, showcasing his commitment to advancing medical science and treatment options.
Latest Patents
Among his latest inventions are the KRas G12C inhibitors. These compounds are designed to inhibit the activity of KRas G12C, a critical target in cancer therapy. The present invention specifically relates to compounds that irreversibly inhibit KRas G12C, along with pharmaceutical compositions that comprise these compounds and methods for their use.
Career Highlights
Henry has worked with prominent companies in the biotechnology sector, including Mirati Therapeutics, Inc. and Array Biopharma Inc. His work in these organizations has significantly contributed to the development of innovative treatments for cancer.
Collaborations
Throughout his career, Henry has collaborated with esteemed colleagues such as James F Blake and Mark Joseph Chicarelli. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Henry J Zecca's work in developing KRas G12C inhibitors exemplifies his dedication to innovation in the pharmaceutical industry. His contributions continue to pave the way for advancements in cancer treatment.